Emerade adrenaline pre-filled pens recalled by regulator

Emerade adrenaline pre-filled pens recalled by regulator

A number of batches of adrenaline pens used in the emergency treatment of acute allergic reactions have been recalled.

The Health Products Regulatory Authority (HPRA) announced that PharmaSwiss is recalling all batches of Emerade 150mcg pre-filled pens, Emerade 300mcg pre-filled pens and Emerade 500mcg pre-filled pens.

The recall is taking place as some Emerade pens may fail to produce an injection when used, due to failure of the pen to activate and the potential for a blocked needle.

The HPRA has called on anyone who possesses an Emerade pen for their own use or for someone in their care to ensure that their pens are brought back to their pharmacy and immediately replaced with an alternative product.

No other brand of adrenaline pens is impacted by this recall.

The affected products are all batches of:

  • Emerade 150mcg pre-filled pens

  • Emerade 300mcg pre-filled pens

  • Emerade 500mcg pre-filled pens

    The HPRA advised users of the recalled products that, if they have not yet been contacted by their pharmacist, that they should check for any Emerade pens in their possession and in other locations.

    "If you are in the possession of any Emerade pen, please return it to your pharmacy where you will receive a replacement alternative product. In line with existing medical guidelines, it is advised that patients continue to carry two pens at all times," said a statement.

    Emerade is administered through a pre-filled pen, or autoinjector.

    The reason for the recall is that a number of reports of failure to activate have been received on other markets.

    The cause of these activation failures and the defect rate remain unknown.

    This is also a separate issue to a potential needle blockage issue for Emerade pens which was previously communicated by the HPRA in July 2018 and July 2019.

    It is possible, however, for both defects to be present in a pen with the potential for failure of administration of the medication.

  • More on this topic

    Harris considering banning e-cigarettes ads near schools and playgroundsHarris considering banning e-cigarettes ads near schools and playgrounds

    'I am extremely grateful' - Country's first liver and double lung transplant recipient'I am extremely grateful' - Country's first liver and double lung transplant recipient

    Ireland's first ever liver and double lung transplant patient making plans for the futureIreland's first ever liver and double lung transplant patient making plans for the future

    Billy Connolly: ‘You don’t wake up famous, you wake up scratching yourself like everybody else’Billy Connolly: ‘You don’t wake up famous, you wake up scratching yourself like everybody else’


    More in this Section

    Mining experts to assess the risk of West Cork sinkholeMining experts to assess the risk of West Cork sinkhole

    Residents in Leitrim continue round-the-clock protest against centre for asylum seekersResidents in Leitrim continue round-the-clock protest against centre for asylum seekers

    Developer offers to lease almost 500 apartments for social homes in CoolockDeveloper offers to lease almost 500 apartments for social homes in Coolock

    Revised plans for controversial Bus Connects plan to be unveiledRevised plans for controversial Bus Connects plan to be unveiled


    Lifestyle

    Lacemakers in Limerick want to preserve their unique craft for future generations and hope to gain UNESCO heritage status, writes Ellie O’Byrne.Made in Munster: Lace-making a labour of love rather than laborious industry

    More From The Irish Examiner